INNOVATIVE healthcare solutions provider Novartis Malaysia’s unwavering commitment to changing the treatment paradigms of cardiovascular disease (CVD) outcomes in Malaysia was recognised at the recent regional level Marketing-Interactive PR Awards 2024.
The winning campaign, titled “Bending the Curve of Life: Changing the Treatment Paradigms of Cardiovascular Disease in Malaysia,” won gold in the category of Best PR Campaign under Healthcare and Pharmaceuticals by beating out tough competitors from across Southeast Asia, South Asia and Oceania regions.
Distinguished by its multi-faceted approach, the campaign ingeniously integrated various communication channels, including digital media, traditional advertising and community engagement initiatives.
This is in line with Novartis Malaysia’s aim to empower individuals by equipping them with crucial knowledge about CVD risk factors, prevention measures, early detection and innovative treatment options.
The hallmark of this ground-breaking campaign lies in the introduction of six innovative initiatives which are laser-focused on raising awareness of cholesterol risk factors among Malaysians.
To achieve this, Novartis Malaysia forged 14 continuous and collaborative partnerships across government agencies, healthcare professionals (HCPs) and the public.
“This prestigious award serves as a testament to Novartis Malaysia’s unwavering dedication in championing cholesterol awareness and transforming cardiovascular disease management in Malaysia,” commented Novartis Malaysia’s country president Mohamed Elwakil.
“We believe that by fostering sustainable partnerships within the healthcare ecosystem, we can inspire collective action and drive meaningful behavioural changes towards achieving optimal heart health.”
Added Elwakil: “Our aspiration is to envision a world where cardiovascular disease is effectively managed, granting patients the opportunity to live longer, healthier lives.
“To accomplish this, we will continue to forge productive collaborations with healthcare systems, pioneering groundbreaking approaches that challenge the status quo and disrupt the conventional treatment paradigms.”
Meanwhile, the healthca5e outfit’s country communications & patient advocacy head Melissa Hon explained that the prime objective of the said campaign was to enhance Malaysians’ understanding of the risk factors associated with an ‘invisible’ disease.
“By utilising innovative communication channels and engaging communities, we have educated individuals about risk factors, prevention, and treatment options,” she shared.
“This accomplishment highlights the exceptional belief, collaboration and unwavering commitment of all stakeholders to bring their ‘A’ Game to take on a particularly challenging disease area.
“We extend our gratitude to our partner agencies, Acendus Communications, Afterhours Events & Marketing Services, and Eyescream Productions in supporting our purpose of improving and extending the lives of over 32 million Malaysians.” – June 20, 2024
